Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Inclusion Criteria:

• Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
• BMI <35 kg/m2
• Ability to give informed consent

Exclusion Criteria:

• History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
• Age ≤18 years
• Patients presenting with pregnancy
• Patients without informed consent
• Expected life expectancy <2 years